Amylyx Pharmaceuticals, Inc. (AMLX) Insider Trading

Name: Amylyx Pharmaceuticals, Inc. (AMLX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 14, 2026): Bedrosian Camille L (Chief Medical Officer): Sale of 7,947 shares, $256.0K.

Get alerted when insiders trade AMLX

Email address

Loading company data...

Beta

Loading company details...

Beta